Assessment of metabolic response to radioimmunotherapy with 90Y-ibritumomab tiuxetan in patients with relapsed or refractory B-cell non-Hodgkin lymphoma.
about
Therapeutic Strategies in HCC: Radiation ModalitiesDiagnostic role of 18F-fluorodeoxyglucose positron emission tomography for follicular lymphoma with gastrointestinal involvement.Targeted radionuclide therapy.Heterogeneity of intratumoral (111)In-ibritumomab tiuxetan and (18)F-FDG distribution in association with therapeutic response in radioimmunotherapy for B-cell non-Hodgkin's lymphoma.Dynamic metabolic changes during the first 3 months after 90Y-ibritumomab tiuxetan radioimmunotherapy.F-18 FDG PET/CT quantization parameters as predictors of outcome in patients with diffuse large B-cell lymphoma.
P2860
Assessment of metabolic response to radioimmunotherapy with 90Y-ibritumomab tiuxetan in patients with relapsed or refractory B-cell non-Hodgkin lymphoma.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Assessment of metabolic respon ...... y B-cell non-Hodgkin lymphoma.
@en
Assessment of metabolic respon ...... y B-cell non-Hodgkin lymphoma.
@nl
type
label
Assessment of metabolic respon ...... y B-cell non-Hodgkin lymphoma.
@en
Assessment of metabolic respon ...... y B-cell non-Hodgkin lymphoma.
@nl
prefLabel
Assessment of metabolic respon ...... y B-cell non-Hodgkin lymphoma.
@en
Assessment of metabolic respon ...... y B-cell non-Hodgkin lymphoma.
@nl
P2093
P356
P1433
P1476
Assessment of metabolic respon ...... y B-cell non-Hodgkin lymphoma.
@en
P2093
Amalia De Renzo
Anna Nardelli
Antonio Speranza
Bruno Rotoli
Fabiana Perna
Giovanni Storto
Leonardo Pace
Michele Klain
Paola Erra
Teresa De Falco
P304
P356
10.1148/RADIOL.09090603
P407
P577
2010-01-01T00:00:00Z